Cargando…

Clinical utility of anti‐cytosolic 5’‐nucleotidase 1A antibody in idiopathic inflammatory myopathies

OBJECTIVE: To define the clinicopathologic features and diagnostic utility associated with anti‐cytosolic 5′‐nucleotidase 1A (NT5C1A) antibody seropositivity in idiopathic inflammatory myopathies (IIMs). METHODS: Anti‐NT5C1A antibody status was clinically tested between 2014 and 2019 in the Washingt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikenaga, Chiseko, Findlay, Andrew R., Goyal, Namita A., Robinson, Sarah, Cauchi, Jonathan, Hussain, Yessar, Wang, Leo H., Kershen, Joshua C., Beson, Brent A., Wallendorf, Michael, Bucelli, Robert C., Mozaffar, Tahseen, Pestronk, Alan, Weihl, Conrad C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7951108/ https://www.ncbi.nlm.nih.gov/pubmed/33556224 http://dx.doi.org/10.1002/acn3.51294

Ejemplares similares

Immune myopathies with perimysial pathology: Clinical and laboratory features
por: Bucelli, Robert C., et al.
Publicado: (2018)

Phenotypic diversity in an international Cure VCP Disease registry
por: Ikenaga, Chiseko, et al.
Publicado: (2020)

Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology
por: Alshehri, Ali, et al.
Publicado: (2015)

Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker
por: Goyal, Namita A., et al.
Publicado: (2015)

GNE myopathy: History, etiology, and treatment trials
por: Mullen, Jeffrey, et al.
Publicado: (2022)

Establishing prevalence in rare neuromuscular diseases: A lesson from congenital myopathies
por: Bamaga, Ahmed K., et al.
Publicado: (2017)

Anti-Cytosolic 5′-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study
por: Porcelli, Brunetta, et al.
Publicado: (2023)

Anti–Cytosolic 5′‐Nucleotidase 1A Autoantibodies Are Absent in Juvenile Dermatomyositis
por: Rietveld, Anke, et al.
Publicado: (2021)

Provisional practice recommendation for the management of myopathy in VCP‐associated multisystem proteinopathy
por: Roy, Bhaskar, et al.
Publicado: (2023)

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
por: Lilleker, J B, et al.
Publicado: (2017)

Client processing is altered by novel myopathy-causing mutations in the HSP40 J domain
por: Pullen, Melanie Y., et al.
Publicado: (2020)

Substrate-Based Design of Cytosolic Nucleotidase IIIB Inhibitors and Structural Insights into Inhibition Mechanism
por: Kubacka, Dorota, et al.
Publicado: (2022)

Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
por: Cividini, Federico, et al.
Publicado: (2015)

Autoantibodies to Cytosolic 5′-Nucleotidase 1A in Primary Sjögren’s Syndrome and Systemic Lupus Erythematosus
por: Rietveld, Anke, et al.
Publicado: (2018)

Evidence for a Cross-Talk Between Cytosolic 5′-Nucleotidases and AMP-Activated Protein Kinase
por: Camici, Marcella, et al.
Publicado: (2020)

Crystal Structures of the Novel Cytosolic 5′-Nucleotidase IIIB Explain Its Preference for m(7)GMP
por: Monecke, Thomas, et al.
Publicado: (2014)

Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology
por: Uchio, Naohiro, et al.
Publicado: (2018)

A Knock-In Mouse Model for the R120G Mutation of αB-Crystallin Recapitulates Human Hereditary Myopathy and Cataracts
por: Andley, Usha P., et al.
Publicado: (2011)

Recent advances in structure and function of cytosolic IMP-GMP specific 5′nucleotidase II (cN-II)
por: Ipata, Piero Luigi, et al.
Publicado: (2006)

Structural Insights into the Inhibition of Cytosolic 5′-Nucleotidase II (cN-II) by Ribonucleoside 5′-Monophosphate Analogues
por: Gallier, Franck, et al.
Publicado: (2011)

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells
por: Bricard, Gabriel, et al.
Publicado: (2017)

Investigating cytosolic 5′-nucleotidase II family genes as candidates for neuropsychiatric disorders in Drosophila (114/150 chr)
por: Singgih, Euginia L., et al.
Publicado: (2021)

Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy: A GRASP-LGMD study
por: Doody, Amy, et al.
Publicado: (2023)

Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
por: Patzak, Melanie S., et al.
Publicado: (2019)

Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator
por: Pesi, Rossana, et al.
Publicado: (2021)

CYTOCHEMICAL LOCALIZATION OF 5'-NUCLEOTIDASE IN SUBCELLULAR FRACTIONS ISOLATED FROM RAT LIVER : I. The Origin of 5'-Nucleotidase Activity in Microsomes
por: Widnell, Christopher C.
Publicado: (1972)

New family with HSPB8-associated autosomal dominant rimmed vacuolar myopathy
por: Al-Tahan, Sejad, et al.
Publicado: (2019)

Novel mutation in TNPO3 causes congenital limb-girdle myopathy with slow progression
por: Vihola, Anna, et al.
Publicado: (2019)

Expression of Bovine Cytosolic 5′-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous Recombination
por: Allegrini, Simone, et al.
Publicado: (2013)

Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway
por: Pesi, Rossana, et al.
Publicado: (2021)

About Pyrimidine 5’-Nucleotidase Deficiency
por: Özsoylu, Şinasi
Publicado: (2013)

Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy
por: Kadoya, Masato, et al.
Publicado: (2016)

Ecto-5’-nucleotidase: Structure function relationships
por: Sträter, Norbert
Publicado: (2006)

Intracellular Distribution of 5' Nucleotidase in Rat Liver
por: de Lamirande, Gaston, et al.
Publicado: (1958)

Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation
por: Pesi, Rossana, et al.
Publicado: (2018)

Substrate Specificity of Chimeric Enzymes Formed by Interchange of the Catalytic and Specificity Domains of the 5′-Nucleotidase UshA and the 3′-Nucleotidase CpdB
por: Cabezas, Alicia, et al.
Publicado: (2021)

LGMDD1 natural history and phenotypic spectrum: Implications for clinical trials
por: Findlay, Andrew R., et al.
Publicado: (2022)

Results from a 3-year Non-interventional, Observational Disease Monitoring Program in Adults with GNE Myopathy
por: Lochmüller, Hanns, et al.
Publicado: (2021)

Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices: The IPaNeMA Study
por: Wencel, Marie, et al.
Publicado: (2021)

Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma
por: Ray, Arghya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ghaio2n55vgiqbjkmmo9l4q2i7